The global clinical
microbiology market was valued at USD 8.4 billion in 2015 and is expected to
reach a value of USD 16.1 billion by 2024. Key factors driving the market
growth include constant introduction of advanced products coupled with
increasing demand in pharmaceutical, and clinical applications for
investigation and diagnosis of various infectious diseases.
 |
| Global Clinical Microbiology Market, 2014 - 2024 (USD Million) |
The market is rapidly growing
due to the increasing adoption of automated and advanced technologies for
laboratory instruments and analyzers in developed countries. Growing geriatric
population and thereby rising prevalence of infectious diseases is one of the
major factors boosting the adoption of clinical microbiology in healthcare
sector for disease diagnosis and monitoring. In addition, industry is gaining
high momentum with launch of innovative products such as MALDI Biotyper,
GeneXpert and Myla IT performance management solutions. Moreover, with the U.S.
FDA approving the Xpert Carba-R, commercialization of clinical microbiology
devices is expected to increase significantly over the next few years.
In North America, the
government authorities and private companies have significantly contributed
toward technology development, research funding, and commercialization of
clinical microbiology associated devices.
In depth research report on Clinical Microbiology Market
Further Key Findings from the Study Suggest:
·
Rapid adoption of technology
and automation of laboratory work flow, laboratory instrument segement is
expected to be the fastest growing segment with CAGR of 8.6% over the forecast
period.
·
Reagents is the largest segment
with market share of 34.7% in 2015. Repeat purchase of reagents contribute to
its growth thus it is the largest growing segment in market.
·
In 2015, North America
dominated the global market with largest revenue share of 41.0%. The continuous
research on infectious disease treatment, and subsequent grant from government
healthcare agencies are contributing to the development of a strong ecosystem
for the expansion of clinical microbiology in the region.
·
Asia Pacific is expected to
emerge as the fastest growing region during the forecast period. The growing
geriatric population in India, China and Japan leading to increase in the
prevalence of re-emerging infectious diseases such as tuberculosis, cholera and
typhoid in this region are expected to promote the utilization of clinical application
of microbiology in healthcare.
·
The clinical microbiology
Industry is presently dominated by a few key participants such as bioMerieux
S.A., Cepheid Inc., Danaher Corporation and Bruker Corporation. Some of the
prominent players operating in the market include but are not limited to Becton
Dickinson & Company, Hologic Inc., Roche Diagnostics and Alere Inc.
Introduction of automated systems and innovative designs, is expected to
intensify the competition by changing the market dynamics over the forecast
period.
Grand View Research has
segmented the clinical microbiology market by product, application, disease and
region:
Product Outlook (Market revenue in USD Million, 2014 -
2024)
·
Laboratory Instruments
·
Incubators
·
Gram Stainers
·
Bacterial Colony Counters
·
Autoclave Sterilizers
·
Microbial Air Samplers
·
Petri Dish Fillers
·
Culture Systems
·
Microbiology Analyzers
·
Molecular Diagnostic
Instruments
·
Microscopes
·
Mass Spectrometers
·
Reagents
Application Outlook (Market Revenue in USD Million, 2014 -
2024)
·
Respiratory Infections
·
Bloodstream Infections
·
Gastrointestinal Infections
·
Sexually Transmitted Infections
·
Urinary tract Infections
·
Periodontal Infections
Regional Outlook (Market
Revenue in USD Million, 2014 - 2024)
·
North America
o
U.S.
o
Canada
·
Europe
o
UK
o
Germany
·
Asia Pacific
o
Japan
o
China
o
India
·
Latin America
o
Mexico
o
Brazil
·
MEA
o
South Africa
Browse more research reports of this category:
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, the company offers market
intelligence studies ensuring relevant and fact-based research across a range
of industries including technology, chemicals, materials, healthcare and
energy.
For more market analysis reports, please visit: http://www.grandviewresearch.com/
No comments:
Post a Comment